About SenesTech (NASDAQ:SNES)
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including plant-based fertility control, feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was founded in 2004 and is headquartered in Flagstaff, Arizona.
Industry, Sector and Symbol
Industry Agricultural chemicals
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SNES
CUSIPN/A
Phone928-779-4143
Debt
Debt-to-Equity Ratio0.08%
Current Ratio6.78%
Quick Ratio6.31%
Price-To-Earnings
Trailing P/E Ratio-0.42
Forward P/E Ratio-1.48
P/E GrowthN/A
Sales & Book Value
Annual Sales$50,000.00
Price / Sales151.89
Cash FlowN/A
Price / CashN/A
Book Value$0.48 per share
Price / Book0.96
Profitability
EPS (Most Recent Fiscal Year)($1.12)
Net Income$-12,280,000.00
Net Margins-23,626.92%
Return on Equity-194.40%
Return on Assets-150.29%
Miscellaneous
Employees39
Outstanding Shares16,510,000
SenesTech (NASDAQ:SNES) Frequently Asked Questions
What is SenesTech's stock symbol?
SenesTech trades on the NASDAQ under the ticker symbol "SNES."
How were SenesTech's earnings last quarter?
SenesTech (NASDAQ:SNES) issued its quarterly earnings results on Thursday, March, 29th. The company reported ($0.15) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.20) by $0.05. The business earned $0.02 million during the quarter, compared to the consensus estimate of $0.10 million. SenesTech had a negative return on equity of 194.40% and a negative net margin of 23,626.92%. View SenesTech's Earnings History.
What price target have analysts set for SNES?
2 Wall Street analysts have issued twelve-month price objectives for SenesTech's shares. Their forecasts range from $3.00 to $14.00. On average, they anticipate SenesTech's stock price to reach $8.50 in the next year. View Analyst Ratings for SenesTech.
Who are some of SenesTech's key competitors?
Some companies that are related to SenesTech include Soligenix (SNGX), Onconova Therapeutics (ONTX), Valeritas (VLRX), Omega Diagnostics Group (ODX), InVivo Therapeutics (NVIV), Vialogy (NIPT), Vernalis (VNLPY), CHF Solutions (CHFS), OHR Pharmaceutical (OHRP), Windtree Therapeutics (WINT), Lidco Group (LID), Alliqua BioMedical (ALQA), Evgen Pharma (EVG), Acura Pharmaceuticals (ACUR), Neurometrix (NURO), OpGen (OPGN), EpiCept (IMNP) and Phytopharm (IXI).
Who are SenesTech's key executives?
SenesTech's management team includes the folowing people:
- Dr. Loretta Powers Mayer Ph.D., Co-Founder, Chair of the Board, Chief Exec. Officer and Chief Scientific Officer (Age 69)
- Dr. Cheryl Ann Dyer Ph.D., Co-Founder, Pres, Chief Research Officer and Director (Age 66)
- Mr. Thomas C. Chesterman, Chief Financial Officer, Exec. VP, Treasurer and Assistant Sec. (Age 59)
- Ms. Kim Wolin, Exec. VP of Operations & Sec. (Age 63)
- Mr. Paul M. Palz, VP and Corp. Controller
When did SenesTech IPO?
(SNES) raised $15 million in an IPO on Thursday, December 8th 2016. The company issued 1,900,000 shares at a price of $8.00 per share. Roth Capital Partners served as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.
Has SenesTech been receiving favorable news coverage?
Media coverage about SNES stock has trended somewhat positive on Thursday, Accern reports. The research group identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. SenesTech earned a news impact score of 0.24 on Accern's scale. They also gave press coverage about the company an impact score of 45.65 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
How do I buy shares of SenesTech?
Shares of SNES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is SenesTech's stock price today?
One share of SNES stock can currently be purchased for approximately $0.46.
How big of a company is SenesTech?
SenesTech has a market capitalization of $7.93 million and generates $50,000.00 in revenue each year. The company earns $-12,280,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. SenesTech employs 39 workers across the globe.
How can I contact SenesTech?
SenesTech's mailing address is 3140 NORTH CADEN COURT SUITE 1, FLAGSTAFF AZ, 86004. The company can be reached via phone at 928-779-4143 or via email at [email protected]
MarketBeat Community Rating for SenesTech (SNES)
MarketBeat's community ratings are surveys of what our community members think about SenesTech and other stocks. Vote "Outperform" if you believe SNES will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNES will underperform the S&P 500 over the long term. You may vote once every thirty days.
SenesTech (NASDAQ:SNES) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
2 Wall Street analysts have issued ratings and price targets for SenesTech in the last 12 months. Their average twelve-month price target is $8.50, suggesting that the stock has a possible upside of 1,747.83%. The high price target for SNES is $14.00 and the low price target for SNES is $3.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $8.50 | $8.50 | $8.50 | $14.50 |
| Price Target Upside: | 1,747.83% upside | 1,316.67% upside | 1,316.67% upside | 96.74% upside |
SenesTech (NASDAQ:SNES) Consensus Price Target History
SenesTech (NASDAQ:SNES) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 4/4/2018 | Roth Capital | Reiterated Rating | Buy | | Low |  |
| 11/22/2017 | Craig Hallum | Set Price Target | Buy | $8.00 -> $3.00 | N/A | |
(Data available from 4/19/2016 forward)
SenesTech (NASDAQ:SNES) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
SenesTech (NASDAQ SNES) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 27.40%
Institutional Ownership Percentage: 22.36%
SenesTech (NASDAQ SNES) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/21/2017 | Loretta Powers Mayer | CEO | Sell | 6,000 | $0.67 | $4,020.00 | | |
| 12/4/2017 | Cheryl Ann Dyer | Insider | Sell | 6,000 | $0.82 | $4,920.00 | 387,201 | |
| 11/24/2017 | Julia Ann Williams | Director | Buy | 1,700 | $0.90 | $1,530.00 | | |
| 11/21/2017 | Loretta Powers Mayer | CEO | Sell | 6,000 | $0.89 | $5,340.00 | 397,977 | |
| 11/2/2017 | Cheryl Ann Dyer | Insider | Sell | 6,000 | $2.72 | $16,320.00 | 399,201 | |
| 10/20/2017 | Loretta Powers Mayer | CEO | Sell | 6,000 | $1.52 | $9,120.00 | 403,977 | |
| 10/3/2017 | Cheryl Ann Dyer | Insider | Sell | 6,000 | $1.97 | $11,820.00 | 450,545 | |
| 9/22/2017 | Loretta Powers Mayer | CEO | Sell | 6,000 | $1.79 | $10,740.00 | 396,658 | |
| 9/5/2017 | Cheryl Ann Dyer | Insider | Sell | 6,000 | $2.31 | $13,860.00 | 430,212 | |
| 8/21/2017 | Loretta Powers Mayer | CEO | Sell | 6,000 | $2.37 | $14,220.00 | 402,658 | |
| 8/18/2017 | Andrew Altman | COO | Buy | 20,000 | $2.77 | $55,400.00 | 2,600 | |
| 8/17/2017 | Julia Ann Williams | Director | Buy | 9,100 | $2.80 | $25,480.00 | 12,050 | |
| 7/26/2017 | Julia Ann Williams | Director | Buy | 10,000 | $3.21 | $32,100.00 | 11,950 | |
| 7/25/2017 | Grover T Wickersham | Director | Buy | 15,000 | $2.85 | $42,750.00 | 238,600 | |
| 7/17/2017 | Thomas C Chesterman | CFO | Sell | 1,411 | $5.14 | $7,252.54 | 10,287 | |
| 6/12/2017 | Thomas C Chesterman | CFO | Sell | 10,000 | $5.71 | $57,100.00 | 16,287 | |
| 1/27/2017 | Robert E Ramsey Jr | Director | Buy | 7,000 | $7.46 | $52,220.00 | 27,000 | |
| 1/24/2017 | Grover T Wickersham | Director | Buy | 1,000 | $7.42 | $7,420.00 | 224,500 | |
| 12/13/2016 | Grover T Wickersham | Director | Buy | 62,500 | $8.00 | $500,000.00 | 224,500 | |
(Data available from 1/1/2013 forward)
SenesTech (NASDAQ SNES) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | SenesTech (SNES) Upgraded to Hold by Zacks Investment Research
www.americanbankingnews.com - April 18 at 4:14 PM |
| Analysts Set $3.75 Price Target for SenesTech (SNES)
www.americanbankingnews.com - April 13 at 5:21 AM |
 | With A -12.16% Earnings Drop, Did SenesTech Inc (NASDAQ:SNES) Really Underperform?
finance.yahoo.com - April 10 at 5:30 PM |
| SenesTech (SNES) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - April 8 at 11:15 AM |
| Reviewing SenesTech (SNES) & Syngenta (SYT)
www.americanbankingnews.com - April 7 at 1:15 AM |
| Zacks Investment Research Downgrades SenesTech (SNES) to Sell
www.americanbankingnews.com - April 6 at 11:38 AM |
| SenesTech (SNES) Stock Rating Reaffirmed by Roth Capital
www.americanbankingnews.com - April 5 at 11:33 AM |
| SenesTech (SNES) Issues Earnings Results, Beats Estimates By $0.05 EPS
www.americanbankingnews.com - March 30 at 8:48 AM |
 | SenesTech, Inc. (SNES) Reports FY17 EPS Loss of $1.12
www.streetinsider.com - March 30 at 8:28 AM |
| Zacks: Analysts Set $9.38 Target Price for SenesTech Inc (SNES)
www.americanbankingnews.com - March 29 at 9:14 PM |
| SenesTech Announces Year End 2017 Financial and Operational Results
finance.yahoo.com - March 29 at 5:27 PM |
| SenesTech, Inc. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 29, 2018
finance.yahoo.com - March 22 at 5:45 PM |
| SenesTech Inc (SNES) Given Consensus Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - March 19 at 3:08 AM |
| SenesTech to Present at 30th Annual ROTH Capital Conference on March 13, 2018
finance.yahoo.com - March 6 at 5:22 PM |
| Analysts Expect SenesTech Inc (SNES) to Post ($0.19) EPS
www.americanbankingnews.com - March 3 at 5:14 AM |
| SenesTech Inc (SNES) Given $9.38 Consensus Price Target by Brokerages
www.americanbankingnews.com - February 25 at 11:24 PM |
| SenesTech (SNES) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - February 22 at 12:30 PM |
| SenesTech To Provide Investor Update on Sales and Marketing Activities
finance.yahoo.com - February 21 at 5:33 PM |
| Zacks: SenesTech Inc (SNES) Given Consensus Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - February 20 at 5:32 AM |
| SenesTech Inc (SNES) Receives Average Recommendation of "Strong Buy" from Analysts
www.americanbankingnews.com - February 16 at 7:58 AM |
 | BRIEF-Senestech Inc Enters Termination Agreement With Neoventa Solutions
www.reuters.com - February 15 at 7:24 AM |
| Analyzing SenesTech (SNES) & Its Peers
www.americanbankingnews.com - February 5 at 9:14 PM |
| SenesTech Appoints Joe Malinowski as Vice President of Sales
finance.yahoo.com - February 5 at 3:27 PM |
| SenesTech (SNES) Upgraded to "Sell" by ValuEngine
www.americanbankingnews.com - February 4 at 1:16 PM |
| SenesTech and Pestmaster Services Partner to Deploy ContraPest®
finance.yahoo.com - January 31 at 3:29 PM |
| Zacks: SenesTech Inc (SNES) Receives Average Recommendation of "Strong Buy" from Analysts
www.americanbankingnews.com - January 30 at 1:20 PM |
| Jamie Bechtel, JD, PhD Joins the Board of Directors for SenesTech
finance.yahoo.com - January 22 at 3:36 PM |
| Comparing SenesTech (SNES) and Its Rivals
www.americanbankingnews.com - January 16 at 11:24 PM |
| Zacks: SenesTech Inc (SNES) Receives Average Recommendation of "Strong Buy" from Brokerages
www.americanbankingnews.com - January 15 at 5:08 PM |
| Zacks: SenesTech Inc (SNES) Given Consensus Recommendation of "Strong Buy" by Analysts
www.americanbankingnews.com - January 10 at 10:38 AM |
| EPA Approves Label Change That Expands Use of SenesTech's ContraPest in Feedlots
finance.yahoo.com - January 8 at 10:54 AM |
| Zacks: SenesTech Inc (SNES) Receives Average Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - January 3 at 3:12 AM |
| Eiger Biopharmaceuticals (EIGR) versus SenesTech (SNES) Financial Review
www.americanbankingnews.com - January 1 at 7:28 AM |
| SenesTech (SNES) Given New $14.00 Price Target at Roth Capital
www.americanbankingnews.com - December 28 at 11:52 AM |
| Brokerages Set $14.50 Target Price for SenesTech Inc (SNES)
www.americanbankingnews.com - December 18 at 1:52 AM |
| Zacks: Senestech, Inc. (SNES) Given Consensus Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - December 3 at 7:30 PM |
| Head-To-Head Analysis: Mesoblast (MESO) versus Senestech (SNES)
www.americanbankingnews.com - December 1 at 7:46 PM |
| SenesTech Reports Sale of ContraPest For Use at A National Park Service Site in Washington D.C.
finance.yahoo.com - November 27 at 4:14 PM |
| Senestech, Inc. (SNES) Earns "Buy" Rating from Craig Hallum
www.americanbankingnews.com - November 22 at 9:36 AM |
| SenesTech Announces Closing of Public Offering of Common Stock and Warrants to Purchase Common Stock
finance.yahoo.com - November 22 at 8:10 AM |
| Zacks: Senestech, Inc. (SNES) Receives Average Recommendation of "Strong Buy" from Analysts
www.americanbankingnews.com - November 18 at 9:06 PM |
| SenesTech, Inc. (SNES) Prices Offering of Common Stock and Warrants
www.streetinsider.com - November 17 at 6:59 PM |
| SenesTech Announces Pricing of Public Offering of Common Stock and Warrants to Purchase Common Stock
finance.yahoo.com - November 17 at 1:56 PM |
| SenesTech (SNES) Confirmed it's Working with Municipal Government of Washington, D.C. to Develop More Effective Rat Control Program
www.streetinsider.com - November 16 at 9:51 AM |
| SenesTech Confirms Reports of Washington D.C. Program for ContraPest
finance.yahoo.com - November 15 at 10:06 AM |
| Financial Analysis: Senestech (SNES) & Medpace Holdings (MEDP)
www.americanbankingnews.com - November 13 at 3:34 PM |
| Senestech, Inc. (SNES) Announces Earnings Results, Beats Estimates By $0.03 EPS
www.americanbankingnews.com - November 10 at 7:08 PM |
| SenesTech, Inc. (SNES) Signs Pact with Target Specialty Products for ContraPest Distribution
www.streetinsider.com - November 9 at 1:38 PM |
| SenesTech, Inc. to Report Third Quarter Fiscal Year 2017 Financial Results on Wednesday, November 8, 2017
finance.yahoo.com - November 9 at 1:38 PM |
| SenesTech Signs a Distribution Agreement with Target Specialty Products for ContraPest®
finance.yahoo.com - November 9 at 1:38 PM |
SenesTech (NASDAQ:SNES) SEC Filings
This page is loading this company's SEC Filings. Please wait...
SenesTech (NASDAQ:SNES) Income Statement, Balance Sheet and Cash Flow Statement
SenesTech (NASDAQ SNES) Stock Chart for Thursday, April, 19, 2018
Loading chart…
